All regulations
Nonrulemaking
FDA
FDA-2025-P-1808
Requests that the FDA determine whether Klonopin (clonazepam) Tablets, 0.25 mg, approved under New Drug Application (“NDA”) number 017533, held by Cheplapharm Arzneimittel GmbH, has been voluntarily withdrawn for reasons of safety or effectiveness.
Documents
5
Comments
0
Description
CLOSED
Key Dates
Comment Period OpensJun 23, 2025
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Keywords
CDER
Citizen Petition
Hyman Phelps and McNamara PC
determine whether Klonopin clonazepam Tablets
0 25 mg
approved under
New Drug Application number 017533
held by Cheplapharm Arzneimittel GmbH
Data from Regulations.gov